egtazic acid has been researched along with Nociceptive Pain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, L; Cheng, R; Ma, Q; Pan, X; Wang, G; Wang, L; Wang, W; Wu, H; Zhang, J; Zhang, M | 1 |
1 other study(ies) available for egtazic acid and Nociceptive Pain
| Article | Year |
|---|---|
Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools.
Topics: Analgesics; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Chelating Agents; Calcium Chloride; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Male; Mice, Inbred ICR; Nociception; Nociceptive Pain; Phosphorylation; Reaction Time; Resveratrol; Ryanodine; Spinal Cord; Stilbenes; Time Factors | 2017 |